Protein-resistant, reductively dissociable polyplexes for in vivo systemic delivery and tumor-targeting of siRNA

Biomaterials. 2013 Mar;34(9):2370-9. doi: 10.1016/j.biomaterials.2012.12.004. Epub 2013 Jan 5.

Abstract

Small interfering RNA (siRNA) has been considered as a very attractive therapeutic alternative to chemical drugs; however, the chemical and biological instability and poor delivery efficiency of siRNA limit its success in clinical applications. Here we report a protein-resistant, reductively dissociable siRNA delivery system based on self-assembled polyelectrolyte complexes of dextran-siRNA conjugates linked by disulfide bonds. The prepared polyplexes exhibit excellent dispersion stability in the presence of serum because of the anti-fouling property of dextran exposed onto the complex surface. The enzymatic degradation of siRNA is also effectively suppressed within the complex. Folates are introduced as an active tumor-targeting moiety via the conjugation of folates to the hydroxyl groups of dextran. An in vivo investigation with a xenograft tumor mouse model shows that the folate-decorated dextran-siRNA conjugates are very efficiently targeted to cancer cells and induce sequence-specific gene silencing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Survival
  • Dextrans / chemistry
  • Disease Models, Animal
  • Female
  • Folic Acid / chemistry
  • Gene Silencing*
  • Gene Transfer Techniques*
  • HeLa Cells
  • Humans
  • KB Cells
  • Mice
  • Mice, Nude
  • Nanoparticles / chemistry
  • Neoplasms / genetics
  • Neoplasms / pathology
  • Polyethyleneimine / chemistry
  • Protein Conformation
  • RNA, Small Interfering / metabolism*
  • Transfection

Substances

  • Dextrans
  • RNA, Small Interfering
  • Polyethyleneimine
  • Folic Acid